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The adrenal cortex is characterized by three histologically and functionally distinct 
zones: the outermost zona glomerulosa (zG), the intermediate zona fasciculata, and 
the innermost zona reticularis. Important aspects of the physiology and maintenance 
of the adrenocortical stem/progenitor cells have emerged in the last few years. Studies 
have shown that the adrenocortical cells descend from a pool of progenitors that are 
localized in the subcapsular region of the zG. These cells continually undergo a process 
of centripetal displacement and differentiation, which is orchestrated by several para-
crine and endocrine cues, including the pituitary-derived adrenocorticotrophic hormone, 
and angiotensin II. However, while several roles of the endocrine axes on adrenocortical 
function are well established, the mechanisms coordinating the maintenance of an 
undifferentiated progenitor cell pool with self-renewal capacity are poorly understood. 
Local factors, such as the composition of the extracellular matrix (ECM) with embedded 
signaling molecules, and the activity of major paracrine effectors, including ligands of 
the sonic hedgehog and Wnt signaling pathways, are thought to play a major role. 
Particularly, the composition of the ECM, which exhibits substantial differences within 
each of the three histologically distinct concentric zones, has been shown to influence 
the differentiation status of adrenocortical cells. New data from other organ systems and 
different experimental paradigms strongly support the conclusion that the interactions of 
ECM components with cell-surface receptors and secreted factors are key determinants 
of cell fate. In this review, we summarize established and emerging data on the paracrine 
and autocrine regulatory loops that regulate the biology of the progenitor cell niche and 
propose a role for bioengineered ECM models in further elucidating this biology in the 
adrenal.
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iNTRODUCTiON
In vertebrates, adrenal steroid hormones are effectors of different adaptive responses to oscillations 
in the organism’s internal and external environment, broadly referred as stress. Adrenal steroid 
hormones serve to modulate a wide range of processes that are central to physiologic response to 
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stress, including energy metabolism, immune response, electro-
lyte homeostasis, and fluid balance. The three main classes of 
adrenal steroid hormones, mineralocorticoids, glucocorticoids, 
and androgens, are produced by the adrenal cortex under the 
tight regulation of distinct and independent endocrine regulatory 
loops: the renin–angiotensin–aldosterone system (RAAS) and 
the hypothalamus–pituitary–adrenal (HPA) axis. The ability of 
the adrenal gland to respond independently to these endocrine 
signals is dependent upon subpopulations of steroidogenic cells 
with distinct morphological and functional characteristics that 
are localized in specific concentric compartments (zones) of 
the cortex. In humans, three histologically distinct zones are 
evident: the outermost zona glomerulosa (zG), the intermediate 
zona fasciculata (zF), and the innermost zona reticularis (zR), 
which are responsible for the production of mineralocorticoids, 
glucocorticoids, and androgens, respectively (1). Although the 
morphological and physiological aspects of the adrenal cortex 
have been relatively well characterized, the regulatory mecha-
nisms responsible for the establishment and maintenance of the 
three zones are not fully understood.
In the last few years, sophisticated molecular techniques, 
such as lineage tracing, and genetically modified animals have 
significantly contributed to our understanding of the embryonic 
development and homeostasis of the adrenal cortex, illuminating 
key molecules and signaling pathways that are implicated in these 
processes (discussed below in Sections “Progenitor Populations 
in the Adrenal Gland” and “Signaling Pathways and Adrenal 
Progenitors”). Accordingly, the Wnt and the hedgehog pathways 
have emerged as major paracrine factors that regulate both 
organogenesis and homeostasis of the gland. Both are essential 
for the establishment and maintenance of an undifferentiated 
population of steroidogenic precursor cells in the periphery of the 
organ that continuously replenish the cortical cells of the three 
zones throughout life (discussed below in Sections “Progenitor 
Populations in the Adrenal Gland” and “Signaling Pathways and 
Adrenal Progenitors”). While the effectors of the RAAS and the 
HPA axis [angiotensin 2 and adrenocorticotrophic hormone 
(ACTH), respectively] are considered primary endocrine 
mediators that promote activity of adrenocortical steroidogenic 
cells (2–4), recent data support that the microenvironment, 
comprised of the extracellular matrix (ECM), its associated 
proteins, and several paracrine and autocrine factors, are also 
major determinants of cell behavior and fate (discussed below 
in Sections “Signaling Pathways and Adrenal Progenitors” and 
“The Adrenocortical Progenitor Niche”). Emerging data support 
an important role for non-steroidogenic/mesenchymal-like 
cells that lie in the adrenal capsule in the maintenance of the 
adrenocortical progenitor pool (5–8). This review focuses on 
the role of microenvironmental factors and signaling pathways 
that contribute to the maintenance of the adrenal cortex. We 
will discuss emerging data on the role of specific paracrine and 
autocrine loops between capsular/stromal cells and cortical cells 
in establishing a specialized microenvironment that supports 
and maintains the adrenal progenitors throughout the life—the 
niche—and how this signaling contributes to the anatomical and 
functional zonation of the adrenal cortex.
DeveLOPMeNTAL ORiGiNS OF THe 
ADReNAL CORTeX
The adrenal cortex originates from cells of the celomic epithe-
lium, which in the mammalian embryo is composed of a single 
squamous cell layer that covers the external surface of the viscera 
and the inner surface of the body wall. Around embryonic day 
9.5 (E9.5) in mice, and during the fourth to sixth weeks of human 
gestation, a thickening of the celomic epithelium between the 
urogenital ridge and the dorsal mesentery forms the adrenogo-
nadal primordium (AGP). At the eighth week of human gestation 
(E10.5 in mice), the AGP divides into dorsomedial and ventro-
lateral portions, giving rise to the adrenal and gonadal primordia, 
respectively (1, 9–11).
Between the weeks 8 and 9 of human gestation (E13 in mice), 
the adrenal primordium is invaded by cells of the neural crest that 
coalesce centrally to form the adrenal medulla (12). Subsequently, 
the adrenal primordium is surrounded by mesenchymal cells, 
which will ultimately form the adrenal capsule (13). At this point, 
compartmentalization of the adrenal cortex into two structur-
ally distinct areas is evident: a central area, comprised of large 
polyhedric eosinophilic cells referred as the “fetal zone,” and a 
peripheral zone adjacent to the newly formed capsule comprised 
of small and basophilic cells, referred to as “the definitive zone.” 
While in mice this compartmentalization is subtle, in humans, the 
fetal zone predominates over the definitive zone, constituting up 
to 80% of the adrenal mass by the end of the gestation (9, 14). In 
addition, ultrastructural studies in humans have demonstrated the 
presence of a third zone, referred as the “transitional” or “interme-
diate zone,” which has intermediate morphologic characteristics 
between the fetal and the definitive zones (9). It has been suggested 
that after mid-gestation the transitional zone has the capacity to 
synthesize cortisol (9, 15). By the week 30 of human gestation, the 
definitive and the transitional zones have morphological features 
that resemble the adult zG and zF, respectively (16). In humans, 
the fetal cortex starts to regress by apoptosis soon after birth, 
completely disappearing after a few weeks (9). In mice, definitive 
evidence about the presence of a transient fetal zone was provided 
by the identification of the fetal adrenal-specific enhancer (FAdE), 
which is only active during early fetal development (see below). 
The differentiation process of the human adrenal cortex continues 
until the onset of puberty, when the definitive cortex completes its 
organization into the three distinct histologic zones that charac-
terize the adult cortex of human and higher primates (14). While 
the zG and the zF are evident at birth, the androgen-producing 
zR only starts to form a few years later, marking the onset of the 
adrenarche, which is the earliest stage of sexual maturation and a 
precursor of puberty (17).
A transcription factor critical for adrenocortical develop-
ment and homeostasis is steroidogenic factor 1 (SF1, also known 
as adrenal four-binding protein or nuclear hormone receptor 
Ad4BP, encoded by the gene NR5A1). All cells that belong to 
steroidogenic lineages of the adrenal and gonads express SF1, 
including subpopulations of long-term retained progenitor 
cells in each organ (8, 18). Therefore, SF1 expression defines 
the identity of these cells and commitment to steroidogenic 
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differentiation (14, 19, 20). The expression of SF1 is detectable 
early in fetal life, between the AGP formation and the ultimate 
establishment of the adrenal primordium (14, 18). Genetic loss of 
Nr5a1 or its upstream transcriptional regulators Pbx1, Wt1, and 
Cited2, interferes with AGP formation leading to various degrees 
of adrenal hypoplasia in mice (12, 14, 21–23). While Nr5a1 is 
continuously expressed from the time of adrenal primordium 
formation throughout the adult life, during embryonic stages 
and early fetal life in mice, the Nr5a1 expression is driven by 
the fetal adrenal-specific enhancer (FAdE), which becomes inac-
tive when the definitive cortex forms, suggesting that distinct 
mechanisms sustain Nr5a1 expression in the fetal and in the 
definitive cortex (14).
While the enhancer that is responsible for initiation and 
maintenance of Nr5a1 expression in the definitive zone is cur-
rently not known, lineage-tracing experiments performed by 
Zubair et  al. have shown that FAdE-driven-Ad4bp-expressing 
cells are indeed precursors of most, if not all, Sf1-expressing 
cells of the definitive cortex (14). It has since been demonstrated 
that after extinguishing FAdE-dependent SF1 expression, some 
cells become embedded within the coalescing capsule and later 
reemerge as FAdE-independent SF1-expressing cells during the 
formation of the definitive cortex (24).
Steroidogenic factor 1 not only defines the identity/specifica-
tion of the cells of the definitive cortex but also serves as a key 
regulator of hormone-dependent steroidogenesis, the hallmark 
of a differentiated adrenocortical cell. In this regard, the effects 
of ACTH on differentiation and steroidogenesis are partially 
mediated by an SF1-induced transcription of steroidogenic 
enzymes that defines a cortisol-producing cell (25). It remains 
unclear, however, how a subpopulation of SF1-expressing cells 
are spared from the pro-differentiation effects of ACTH, pre-
serving their undifferentiated state. One clue to such regulation 
comes from studies of DAX1, an atypical nuclear receptor that 
is encoded by the gene NR0B1 and expressed preferentially in 
the peripheral/subcapsular cortex. DAX1 functions as a repressor 
of SF1-mediated transcription and has been shown to have an 
important role in the maintenance of the undifferentiated state 
(lack of steroidogenesis) of the adrenocortical progenitor popula-
tion (26). Studies examining the consequences of genetic loss of 
DAX1 in the adrenal revealed an unexpectedly hyper-functional 
zF in younger mice, characterized by an increase in cell prolifera-
tion and steroid production. Surprisingly, as the animals aged, 
they developed adrenal hypofunction consistent with an abnor-
mal premature differentiation of the progenitor cell pool that 
ultimately resulted in its exhaustion (27, 28). In the next section, 
we will briefly summarize studies that have begun to explore the 
molecular and cellular processes that underlie the homeostasis of 
the progenitor cell population.
PROGeNiTOR POPULATiONS  
iN THe ADReNAL GLAND
One of the first reports regarding adrenal regeneration in rats 
describes the restoration of the adrenal cortex 6 weeks after uni-
lateral adrenal enucleation, a process that involves the removal of 
the inner content of the adrenal gland (including the medulla), 
while leaving the capsule and underlying subcapsular cells intact. 
This observation suggested the presence of an adrenocortical 
stem and/or progenitor cell population located in the periphery 
of the adrenal gland (29). The notion of a renewing progenitor 
population in the adrenal cortex was corroborated by the observa-
tion that transplants of bovine adrenocortical cells underneath 
the kidney capsules of adrenalectomized immunocompromised 
mice can give rise to adrenocortical tissue with steroidogenic 
properties (30, 31).
The presence of a progenitor cell population in the periphery 
in the adrenal gland that gives rise to all the differentiated cell 
types within the different cortical zones is consistent with a 
homeostatic model of centripetal migration and differentiation. 
This idea was first hypothesized in the 19th century, based on 
histological observations of gradual changes in morphology 
observed in cells between the capsule and the medulla (32, 33) 
[reviewed in Ref (34)]. Over the years, different studies have 
shown that, under physiological conditions, proliferating cells 
are located preferentially in the outermost layers of the cortex, in 
the subcapsular region (35, 36). Also, it has been demonstrated 
that peripheral cortical cells are centripetally displaced until they 
reach the cortical–medullary boundary and become apoptotic 
(35, 37). Moreover, studies performed in chimeric and transgenic 
mosaic rats and mice have shown a radial variegated pattern of 
the reporters extending from the outer cortex to the cortico-med-
ullary boundary. This observation is consistent with a peripheral 
clonal origin (38–40). Definitive genetic evidence for a centripetal 
conversion of adrenocortical cells between concentric zones was 
finally provided by cell-lineage tracing (8, 41). In one of these 
studies, transgenic mice were created with a Cre recombinase 
gene inserted at the Cyp11b2 locus, in which Cre was expressed 
only in terminally differentiated zG cells (41). When these mice 
were crossed with mice expressing the R26RmT/mG reporter, GFP-
positive cells that occupied the zG upon Cyp11b2-Cre expression, 
eventually populated the entire cortex. Over time, an increasing 
number of centripetally located Cyp11b1-expressing cells were 
found to express GFP, indicating that peripheral zG cells under-
went lineage conversion to more centripetal zF cells. In 12-week 
old mice, nearly the entire cortex was comprised of GFP-positive 
cells. Although these existing data strongly support the existence 
of a progenitor population localized in the periphery of the gland 
that gives rise to all the steroidogenic cells types of the cortex 
through a process of centripetal displacement/migration and dif-
ferentiation, the molecular mechanisms that govern this process 
are not completely understood.
Further studies have provided clues on the molecular fin-
gerprint of the progenitor cell populations and the signaling 
pathways that regulate their renewal and differentiation. Specific 
paracrine/autocrine signaling pathways are activated in zonally 
restricted patterns that reflect the different cell subpopulations 
that are hypothesized to play an active role in organ homeostasis. 
The most important and well characterized are the Wnt and the 
hedgehog pathways. Additionally, a cross-talk between cortical 
cells and capsular stromal cells regulates the activity of these 
pathways. Below, we briefly summarize these findings.
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SiGNALiNG PATHwAYS AND ADReNAL 
PROGeNiTORS
wnt Signaling Pathway
The mammalian wingless-type MMTV integration site (Wnt) 
signaling pathway is one of the most studied pathways in devel-
opmental biology, playing important roles in organogenesis, 
homeostasis, and stem cell biology (42). Wnt ligands represent a 
large family of highly conserved morphogens that are character-
ized by repetitive cysteine residues. Secreted Wnt ligands bind 
to receptors of the Frizzled and lipoprotein receptor-related 
protein families on the cell surface. Through several cytoplasmic 
components, the signal is either transduced through β-catenin, 
which enters the cell nucleus and complexes with T-cell factor/
lymphocyte enhancer factor (TCF/LEF) family of transcription 
factors to activate transcription of Wnt target genes (canonical 
pathway), and/or activates the non-canonical Wnt pathway to 
regulate planar cell polarity and calcium signaling (42). In the 
mouse adrenal gland, β-catenin expression is first observed at 
E12.5 in Sf1+ cells of the definitive cortex in a scattered fashion 
beneath the newly formed capsule (43). After E18.5 and through-
out life, β-catenin protein expression becomes more enriched in 
cells of the zG, which have also been demonstrated to bear active 
canonical Wnt signaling (43, 44).
Canonical Wnt signaling plays several roles in the adrenal 
cortex. Recent evidence demonstrates that the population of 
Wnt-responsive cells is heterogeneous and contains small clusters 
of Shh-producing cells (considered to be adrenal progenitors, as 
it will be discussed later) and separate differentiated Cyp11b2-
expressing cell clusters (44). Interestingly, despite the well-known 
role of Wnt signaling pathway in promoting cell proliferation in a 
variety of organ systems, the Wnt-responsive cells do not appear 
to be heavily proliferating, implying that any role of Wnt signaling 
in adrenal homeostatic growth might involve a potential cell non-
autonomous mechanism (44).
The Wnt pathway is essential for the establishment and main-
tenance of the subcapsular progenitor cell population. However, 
it does not appear to play a role in the early formation of the AGP 
since expression of Ctnnb1 is first detectable in mesothelial cells 
overlying the indifferent gonad at around E11.5 and in the adre-
nal primordium at around E12.5, following their separation from 
the AGP (43, 45). Studies performed in a Nr5a1/Cre-mediated 
Ctnnb1 conditional knockout mouse model (Ctnnb1tm2kem 
mice crossed into Sf1/Cre-high mice), in which canonical Wnt 
signaling to adrenal primordium SF1-expressing cells from 
around E12.5 is reduced or absent reveal a marked decrease in 
cortical cell proliferation which ultimately results in the com-
plete regression of the adrenal gland by E18.5, despite normal 
formation of the adrenal primordium at earlier time points (43, 
46). Loss of β-catenin in approximately 50% of Sf1-expressing 
cells and hence a resultant ~50% decrease in β-catenin-mediated 
Wnt signaling (induced by a low efficiency Sf1/Cre-low driver 
that allows for a subset of cells to escape recombination) results 
in a histologically normal adrenal through 15 weeks of age, after 
which the adrenal cortex undergoes progressive thinning over 
time and ultimate adrenal failure (43, 46). Consistent with a pri-
mordial role of the Wnt signaling in maintaining the progenitor 
cell population, it has been demonstrated that Nr0b1 (Dax1) 
is a transcriptional target of β-catenin, suggesting that both 
proteins synergistically act to maintain the undifferentiated state 
that characterizes the progenitor cell population (28). Together, 
these evidences suggest that canonical Wnt signaling has a role in 
establishing and maintaining a pool of adrenocortical progeni-
tors throughout life.
Hedgehog Signaling Pathway
The hedgehog signaling pathway (Hh) is a conserved evolutionary 
pathway that is essential for embryonic development and adult 
tissue maintenance, renewal, and regeneration. Three secreted 
hedgehog proteins have been described: sonic hedgehog (SHH), 
desert hedgehog, and Indian hedgehog. These proteins function 
in a concentration- and time-dependent fashion, controlling 
several processes ranging from survival and proliferation to cell 
fate specification and differentiation (47).
Shh is the only Hh family member that is present in the murine 
adrenal gland, being detected as early as E12.5 and later expressed 
in a restricted manner in a subpopulation of cells in the outer zG 
(8). These cells are Sf1-positive and do not express Cyp11b2 or 
Cyp11b1, the enzymes necessary for terminal reactions that lead 
to aldosterone and corticosterone production, respectively. While 
in the mouse adrenal the Shh+ cells are localized in clusters under 
the capsule, in the rat these cells form a continuous layer localized 
between the zG and the zF, known as the undifferentiated zone 
(zU) (48).
Lineage-tracing studies that mark all Shh-expressing cells and 
their descendants reveal that, by postnatal day 12 (P12), virtu-
ally all cells of the cortex are derived from Shh-expressing cells, 
consistent with a role for Shh in the peripheral stem/progenitor 
cells (8). Studies utilizing an inducible Shh-Cre recombinase have 
demonstrated that shortly after recombination in adult mice, Shh-
expressing cells, and their immediate descendants are restricted 
to the periphery of the cortex. Over time, these cells and their 
descendants form centripetally expanding radial stripes, support-
ing the hypothesis that the Shh-expressing cells are a progenitor 
population that gives rise to all other cortical cell populations (8). 
BrdU-labeling experiments carried out on rat adrenals identified 
two sites of proliferation in the outer zF and inner zU and between 
the zG and zU, suggesting that cell proliferation at the periphery 
of the zU provides cells to both zG and zF (36). However, the 
proliferative capacity of these cells is more consistent with their 
identification as progenitors rather than as stem cells as suggested 
by the authors. Another study on mouse adrenocortical cell 
proliferation used BrdU pulse-chase labeling to identify a small 
population of quiescent non-steroidogenic cells located in the 
outer cortex that may represent a quiescent progenitor popula-
tion, which is prompted to divide following ACTH stimulation 
(35). Additionally, this study suggested that two distinct subpopu-
lations of rapidly cycling cells emerged from the progenitor popu-
lation—the first constituted by cells that proliferate in response 
to ACTH and migrate inwards and the second constituted by 
cells that migrate outwards and are less responsive to ACTH. The 
authors have suggested that these distinct subgroups of cells are 
committed transient-amplifying cells that are responsible for the 
maintenance of the zF and zG, respectively (35). Interestingly, 
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another study has shown that Cyp11b2-expressing cells in the zG 
derived from the Shh-expressing cells undergo lineage intercon-
version, differentiating into Cyp11b1-expresing cells in the zF as 
they migrate inwards, suggesting that cells from both zones are in 
fact derived from the same lineage (41).
In addition to serving as a progenitor cell population in the 
cortex, Shh-positive cells presumably signal to Gli1-expressing 
cells that lie within the capsule (48, 49). Interestingly, the capsular 
Gli1-expressing cells are a mesenchymal-like population that do 
not express Sf1 (Gli1+/Sf1−) but descends from the fetal FAdE-
utilizing Sf1+ cells of the adrenal primordium (24). The fate of the 
descendants of these Gli1-expressing cells has been investigated in 
a transgenic mouse model with an inducible Gli1-CreERT2 allele. 
It has been demonstrated that during adrenal development, Gli1+ 
capsular cells behave as stem or precursor cells since they give rise 
to Sf1+ cells of the early definitive cortex that later become the 
Sf1+/Shh+ progenitor cell pool (8).
Other Signaling Pathways
In addition to the Gli+/Sf1− cell population, other mesenchy-
mal-like cell lineages have also been identified in the capsule 
and the stroma. These cells may also have important roles in the 
adrenal gland maintenance. Bandiera and colleagues observed a 
long-retained pool of cells expressing the Wilms tumor protein 
homolog (WT1) in the adrenal capsule that originates from 
capsular mesenchymal cells and is characterized by AGP features 
(50). WT1 is a transcriptional regulator that has important roles 
in organogenesis of different organs, including the adrenals 
and gonads. Using a Wt1-Cre recombinase line crossed with a 
reporter line, Bandiera et al. demonstrated that WT1-expressing 
cells could give rise to steroidogenic cortical cells in the adult 
adrenal and the Gli1+ population as well, lending support for a 
role for WT1 in the activation of Gli1 transcription.
Wood et al. identified a population of cells in the mouse adrenal 
that starts to express the transcription factor 21 (Tcf21, also known 
as Pod1/capsuling/epicardin) at E9.5 onward. After E14.5, Tcf21 
expression becomes predominately restricted to the capsule and 
further diminishes over time, leaving only a small population of 
capsular Tcf21+ cells through adulthood. Lineage-tracing experi-
ments revealed that before adrenal encapsulation, Tcf21-expressing 
cells and/or their descendants give rise to both non-steroidogenic 
capsular cells and steroidogenic cortical cells. On the other hand, 
the population of Tcf21-expressing capsular cells only gives rise to 
a population of Sf1− stromal cells that express collagen, desmin, 
and Pdgfrα and persist throughout adult life within the cortex (24).
Taken together, these studies provide evidence that the capsule 
is a complex niche comprised of multiple long-term retained 
cell lineages. The roles of each of these populations in the adult 
adrenal remain unknown, but recent evidence suggests that 
signaling coming from the capsule is required for the long-term 
maintenance of the adrenocortical progenitor cells.
THe ADReNOCORTiCAL  
PROGeNiTOR NiCHe
The proper balance of progenitor proliferation and differentiation 
is crucial, as dysregulation of the mechanisms that regulate the 
differentiation, proliferation, and self-maintenance of progenitor 
cells throughout life can result in organ failure. Stem and progeni-
tor cells from different organs and tissues are embedded within a 
specialized microenvironment, termed the niche. Niches are pro-
tective locations that support stem cell residence and maintenance. 
Several components of the niche have been identified, including 
bioactive compounds, such as Wnt ligands, growth factors [e.g., 
fibroblast growth factors (FGFs) and epidermal growth factor], 
chemokines, and a distinct ECM composition that sequesters 
growth factor signaling and spatially restricts cell movement 
for appropriate cell–cell interactions. While well-defined niches 
characterized in different organs vary in size and complexity, most 
are maintained by a small set of fundamental regulatory signaling 
loops (51). Although several studies have revealed the importance 
of these signaling pathways in the adrenal biology as coordina-
tors of stem/progenitor cell specification and differentiation, the 
formal structural and molecular definition of an adrenocortical 
progenitor niche remains elusive (52). ECM components are 
predicted to provide additional structural context to zone-specific 
signaling pathways discussed in the previous section. Below, we 
discuss these regulatory mechanisms in further details.
Components of the Adrenocortical Niche
Soluble Factors
Wnt Ligands
As previously discussed, the canonical Wnt/β catenin signaling 
pathway is considered to be a crucial pathway for the mainte-
nance of the subcapsular stem/progenitor pool (44, 46, 53). 
While the source and the contribution of different Wnt ligands 
to Wnt signaling are not currently known, previous observations 
based on adrenal tumors expression profiles, human clinical syn-
dromes, and mouse models suggest that WNT4 is an important 
Wnt regulatory paracrine factor in the adrenal cortex. In humans, 
WNT4 mutations underlie the defects in Serkal syndrome, an 
autosomal recessive disorder characterized by multiple malfor-
mations including adrenal hypoplasia and male-to-female sexual 
reversion (54). In mice, while Wnt4 expression is observed in the 
developing adrenal glands as early as E11.5, by E14.5 it is restricted 
to the outer cortex (46, 55). Additionally, a mouse model of Wnt4 
inactivation suggests that this ligand is required for proper zG 
differentiation and aldosterone production. In these mice, genetic 
loss of Wnt4 decreases Cyp11b2 expression, leading to a dimin-
ished production of aldosterone (55). Interestingly, the anterior 
tips of the developing gonads of these mice exhibit a steroidogenic 
enzyme expression pattern similar to adrenocortical cells, sug-
gesting an abnormal differentiation process or a defect in adrenal 
cell specification during the separation of the AGP (55, 56).
WNT4 is a known transcriptional target of Wnt/β catenin 
signaling (55). In the adrenal cortex, WNT4 expression is 
restricted to the zG, precisely where canonical Wnt pathway is 
known to be active. Additionally, according to our own analysis 
on a recently published molecular profiling study on adrenocor-
tical carcinomas (57), samples with activating exon 3 CTNNB1 
mutations exhibit increased expression of WNT4 in comparison 
to samples without somatic alterations in components of the Wnt 
pathway (fold change  =  17.5, FDR-adjusted p-value <0.001). 
More recently, it has been demonstrated that the expression levels 
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of canonical Wnt target genes are significantly reduced in the 
adrenals of a mouse model of Sf1-Cre mediated Wnt4 knockout 
(Sf1:Cre;Wnt4Fl/Fl) (58). Interestingly, it has also been shown that 
the activation of the protein kinase A pathway enables a zG-to-
zF lineage conversion by antagonizing canonical Wnt signaling, 
which is partially mediated by repression of Wnt4 expression 
(58). Together, these data support a model whereby WNT4 
serves as an autocrine activator of Wnt signaling, amplifying 
canonical (β catenin-dependent) Wnt activation within the zG, 
which is essential for proper zonation. However, whether WNT4 
downstream signaling also induces a non-canonical (β catenin-
independent) effect is currently not known. In other systems, 
WNT4 is described preferentially as a non-canonical ligand (59, 
60). Last, the roles and the sources of other Wnt ligands that are 
expressed in the adrenal are yet to be determined.
Other Wnt Pathway-Related Soluble Factors
Bone Morphogenetic Protein-4 (BMP4) is a ligand of the TGF-β 
superfamily that plays essential roles in embryonic development, 
stem cell biology, and tissue regeneration (61). Recently, Rege 
et  al. have demonstrated that this protein, its receptors, and 
downstream molecules are expressed and have functional roles 
in the human adrenal cortex and in the H295R adrenocortical 
carcinoma cell line. Interestingly, mRNA expression of BMP4 
follows a zonal distribution gradient, with the highest levels in 
the zG, suggesting that BMP4 is a Wnt target gene. In vitro, BMP4 
actively inhibits the expression of 17,20-lyase and DHEA secre-
tion, possibly serving to prevent a zR fate (62). Consistent with the 
observed zonal distribution in the adrenal cortex, BMP4 has been 
reported as a Wnt target gene in a colorectal cancer cell line (63). 
Moreover, according to our own analysis on two independent 
datasets (57, 64), BMP4 mRNA is upregulated in ACC samples 
with nuclear immunostaining for β-catenin or with an activating 
mutation of CTNNB1 in comparison to those with membranous 
immunostaining or wild-type for CTNNB1 somatic mutations 
(fold change >3.21–6.76, FDR-adjusted p-value <0.001). These 
observations suggest that BMP4 is a paracrine factor regulated 
by the Wnt pathway that may have a role in functional zonation 
by inhibiting a zR fate.
Coiled-coil domain containing 80 (CCDC80) has recently 
been described as a novel Wnt target gene in the adrenal cortex. 
In situ hybridization has shown that it is expressed in cells within 
the zG. Functional studies have shown that CCDC80 decreases 
steroidogenesis in  vitro, suggesting, as for BMP4, a role in cell 
differentiation or fate. The molecular pathway by which CCDC80 
regulates steroidogenesis is yet to be determined in the adrenal 
gland (44). In the chick embryo, the CCDC80 homolog equarin 
regulates FGF signaling by increasing its local availability and by 
facilitating the interactions of FGF ligands with FGF receptors and 
proteoglycans (65). Further studies in CCDC80 null mice aiming 
to characterize the overall mechanism of action of CCDC80 in the 
adrenal gland are ongoing.
Sonic Hedgehog
Sonic hedgehog-expressing cells serve as a bona fide progenitor 
population that contributes to the adrenal cortex homeostasis 
in adult life, as previously described. Mice with global genetic 
deletion of Shh exhibit severe adrenal hypoplasia during embry-
onic development due to a reduction in both cortical and capsular 
cell proliferation (8, 66, 67). However, these animals also have 
severe malformations in other organs, including pituitary defects 
that impair ACTH production, making the adrenal phenotype 
difficult to interpret. Moreover, targeted deletion of Shh in 
Sf1-expressing cells in mice also causes adrenal abnormalities, 
indicating that Shh is indeed essential for intrinsic (ACTH-
independent) adrenal development. While AGP separation, 
neural crest migration, and encapsulation occur normally, these 
animals have a hypoplastic adrenal cortex and diminished mitotic 
activity by E13.5. As age increases, progressive cortical thinning 
with an apparent defect in steroidogenesis is observed as reflected 
by a compensatory increase in ACTH levels. Also, an overall 
thinner capsule is also seen (66). The mechanisms by which Shh 
deficiency causes this capsular phenotype are not known, but is 
predicted to result from a defective cortical Shh signaling to the 
capsular Gli1-expressing cells.
Shh is a secreted ligand that binds to the cell-surface receptor 
patched homolog 1 (Ptch1). Shh binding relieves Ptch1-mediated 
inhibition of Smoothened homolog (Smo). Smo stimulates intra-
cellular downstream Shh signaling that, when activated, inhibits 
the otherwise proteolytic degradation of Gli transcription factors, 
resulting in Gli-mediated transcriptional activation of Hh target 
genes (8, 47, 66, 67). Whether a secreted factor produced by Shh-
responsive Gli+ capsular cells is required for maintaining the sub-
capsular progenitor population is currently unknown. Together, 
these observations indicate that the Shh-expressing subcapsular 
progenitor cells and the capsular Gli-expressing cells are integral 
components of the adrenocortical progenitor cell niche.
Fibroblast Growth Factors
The FGFs are a family of secreted signaling proteins that bind to a 
subclass of membrane-bound tyrosine kinase-coupled receptors 
(FGFRs 1–4) and intracellular non-signaling proteins (iFGFs) 
that work as cofactors for other membrane-associated proteins. 
With few exceptions, FGFs are ubiquitous paracrine/autocrine 
factors with essential roles in embryogenesis, organogenesis, 
and tissue homeostasis. FGFs regulate fundamental cellular pro-
cesses, including proliferation (both promoting and inhibiting), 
survival, differentiation, migration, and metabolism. FGFs 
routinely bind to heparin sulfate proteoglycans, which limit their 
diffusion through the ECM and serve as cofactors that regulate 
FGF specificity and affinity to different types of FGFRs (68, 69).
Early studies have demonstrated that FGFs exhibit a potent 
mitogenic effect both in the murine-derived Y1 adrenocortical 
cell line and primary cultures of bovine and human adrenocorti-
cal cells. Interestingly, this effect can be antagonized by ACTH, 
which promotes cell differentiation by inducing cell cycle arrest 
and steroidogenesis in vitro (70–74). In vivo, different combina-
tions of FGF ligands and receptors are expressed in the adrenal 
capsule and cortex, consistent with a proposed role in homeosta-
sis. RT-PCR analysis from laser capture microdissected adrenals 
from E15.5 mouse embryos have shown that Fgf1, Fgf2, and Fgf9 
are the only FGF ligands that are expressed in the embryonic 
adrenal gland. While Fgf1 is expressed in the cortex, Fgf2 and 
Fgf9 are expressed preferentially in the capsule. Additionally, 
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Fgfr1-IIIc, Fgfr2-IIIb, and Fgfr2-IIIc are expressed in cells of both 
the capsule and the cortex. Interestingly, the cortical cells that 
express Fgfr2 are the also Shh-positive (48, 75, 76).
The importance of FGF signaling in adrenal maintenance has 
been revealed through several in vivo studies. FGF2 encapsulated 
in poly-lactic-co-glycolic acid enhances the growth of adrenocor-
tical cells implanted under the kidney capsule of mice by fivefold 
to eightfold (74). Additionally, engineered deletion of the FGF 
ligand, FGF2 or the FGF receptor Fgfr2, results in various degrees 
of adrenal hypoplasia after birth. The global Fgfr2-IIIb knockout 
results in embryonic lethality due to severe malformations, 
including adrenal hypoplasia (7). The same adrenal phenotype was 
recapitulated by a Sf1-driven specific knockout of both Fgfr2-IIIb 
and Fgfr2-IIIc (77). Evaluation of the embryonic adrenal gland 
of Fgfr2-IIIb global knockout mice at E15.5 revealed a marked 
capsular defect, characterized by thickening and disorganization 
of the mesenchymal capsule, with increased mitotic activity and 
increased number of Gli1-positive cells. Meanwhile, the underly-
ing cortex was hypoplastic with a decrease in both steroidogenic 
differentiation and mitotic activity. An unexpected, decrease in 
capsular delta-like protein 1 (Dlk1) suggests that, together with 
Shh and FGFs, Dlk1 is a mediator of the proposed homeostatic 
cross-talk between cortical and capsular cells (75).
Delta-Like Protein 1 (DLK1)
Delta-like protein 1 (also known as preadipocyte factor 1—Pref1) 
is a paternally expressed imprinted gene that encodes an epider-
mal growth factor repeat-containing transmembrane protein. 
Dlk1 is cleaved by the TNF-alpha-converting enzyme (TACE or 
ADAM17) to generate a soluble, secreted, and biologically active 
protein (78, 79). In adipose tissue, DLK1 negatively regulates pro-
liferation and terminal differentiation of adipocyte progenitors 
(80–83). Mechanistically, DLK1 interacts with fibronectin and 
facilitates downstream integrin signaling, which includes MEK/
ERK activation (80). While the human adrenal cortex expresses 
high levels of the DLK1 transcript (the highest levels among all 
human tissues according to the GTEx portal database), little is 
known about its downstream signaling and overall function in 
adrenocortical cells (84). However, in vivo studies in rat reveal 
that Dlk1 expression is markedly decreased in the regeneration 
process following enucleation, suggesting a role in adrenal 
remodeling and zonation. The Dlk1 expression is restricted to 
a subcapsular population in the rat zU (6, 85, 86). Indeed, the 
Dlk1+ cells do not express Cyp11b1 and are rarely positive for 
Cyp11b2. They do, however, express Shh, indicating that they are 
indeed the progenitor population (48, 87). A low-sodium diet 
induces a marked downregulation of both Dlk1 and Shh, with a 
proportional increase in the expression of Cyp11b2. Blocking the 
RAAS with captopril induces the opposite effect—expansion of 
Dlk1 and Shh-expressing cells. Additionally, a population of cap-
sular cells responds directly to Dlk1 signaling by increasing the 
levels of both p-ERK and Gli1, consistent with a role in regulating 
hedgehog signaling (6). These results predict that in the rat adre-
nal, Dlk1 is expressed by the cortical progenitor cell population 
and acts in concert with Shh to activate capsular Gli1, modulating 
differentiation, remodeling, and zonation (6). However, it should 
be noted that these conclusions are based on studies in rat, which 
express Dlk1 in the subcapsular cells whereas, in mice, Dlk1/
Pref1 is expressed in the capsule (6, 75).
R-Spondin Family Member 3 (RSPO3)
R-spondins are secreted proteins that have been recently 
described as important positive regulators of the canonical Wnt 
pathway (88). R-Spondins are paracrine factors that exhibit a 
very low diffusion gradient since these proteins firmly binds to 
certain ECM components such as syndecan-4, remaining close 
to its secretory source (89). In organs, such as the liver and the 
gastrointestinal tract, RSPO3 gradients are a critical determinant 
of regions of active canonical Wnt signaling, being a crucial 
regulator of the stem/progenitor cell compartment, cell differen-
tiation, and functional compartmentalization (90). R-Spondins 
interact with members of the leucine-rich-repeat-containing 
G-protein-coupled receptor (Lgr), which have recently been 
described as surface stem cell markers (91). Clinical evidence 
suggests an important role of R-Spondins in stem cell biology 
and morphogenesis since inactivating mutations in R-Spondin 
genes are associated with syndromes characterized by stem cell 
failure and developmental abnormalities (89). The interaction of 
R-Spondins with the Lgr receptors results in the inactivation of 
the U3-ubiquitin ligases RNF43 and ZNRF3, which are negative 
regulators of Wnt signaling by promoting internalization of the 
Frizzled receptors. Consequently, in the presence of R-Spondins, 
the Frizzled receptor will remain on the membrane allowing 
for Wnt signaling activation (91, 92). A recent paper explores 
the roles of R-Spondins in the regulation of the canonical Wnt 
signaling, functional zonation, and progenitor cell activity in the 
adrenal cortex (5). By using in  situ hybridization, the authors 
demonstrated the expression of Rspo1 and Rspo3 in the adrenal 
capsule of the mouse from E12.5 onward. While Rspo1 co-
localized with the Wt1 mesodermal-like expressing cells, Rspo3 
was preferentially co-expressed with Nr2f2 and Gli1-expressing 
cells. Additionally, the mRNA abundance of Rspo3 was signifi-
cantly higher than Rspo1. Interestingly, while the genetic loss of 
Rspo1 had no observable effects on the adrenals, loss of Rspo3 
was associated with remarkable phenotypes. By using different 
crosses of a Rspo3flox allele and several CreERT drivers, the authors 
demonstrated that (a) loss of Rspo3 results in cortical atrophy 
both during development and postnatally; (b) these changes are 
accompanied by a dramatic decrease in canonical Wnt signal-
ing, which results in loss of the expression of canonical Wnt 
target genes such as Axin2 and Wnt4; (c) loss of a functional zG, 
characterized by profound morphological changes and loss of 
expression of zG markers (while retaining zF differentiation); (d) 
loss of cortical Shh-expressing cells and capsular Gli1-expressing 
cells; and (e) a significant decrease in the mitotic activity of the 
cortex. The authors concluded that capsular-derived Rspo3 is a 
key regulator of both Wnt and Hedgehog signaling in the adrenal 
cortex, having determinant roles in the establishment and the 
maintenance of the stem/progenitor cell populations, and in 
functional zonation (5).
These above findings support a general model whereby sev-
eral autocrine/paracrine mediators from different sources play 
regulatory roles in the major signaling pathways that control 
the progenitor cell compartment and fate determination in the 
FiGURe 1 | Schematic figure representing paracrine signaling in the adrenal cortex. Adrenal zonation is established and maintained by a 
compartmentalized secretion of paracrine factors. The zG is characterized by activation of canonical Wnt signaling, which is dependent on the presence of RSPO3 
secreted by Gli1-expressing capsular cells. Wnt-expressing cells secrete other paracrine factors that regulate the differentiation of cortical cells. Wnt4 amplifies the 
activation of canonical Wnt signaling within the zG, helping in maintaining the zonation. Ccdc80 and is a canonical Wnt target gene that prevents zF differentiation. 
By unknown mechanisms, a small proportion of Wnt-active zG cells, which is a long-living progenitor cell population, secretes Shh, which activates Gli1-dependent 
signaling on the capsular cells. Other paracrine factors, such as Dlk1 and fibroblast growth factors, also have regulatory roles in the maintenance of the cortical 
progenitor cells, presumably by regulating Gli1 expression in the capsule.
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adrenal cortex (Figure  1). Some are known to interact with 
ECM components, indicating that the ECM composition may 
play a role in these regulatory loops. However, several gaps in 
the knowledge about the role of the adrenal ECM in paracrine/
autocrine signaling and cell fate determination remain. In the 
following sections, we summarize the main findings that support 
a regulatory role for the adrenal ECM.
The ECM and Associated Proteins
The ECM is a three-dimensional meshwork of extracellular 
proteins and polysaccharides that supports cells in each tissue 
(93). Among its components are included fibrous proteins such 
as collagens, laminin, fibronectin, and several types of bioactive 
compounds, such as latent growth factors, enzymes, chemoat-
tractants, and morphogens (94). Therefore, in addition to its role 
in providing the physical scaffold that shapes the different tissues 
in an organism, the ECM is a reservoir of several biologically active 
compounds of different sources that are delivered to the cells in 
a spatially controlled manner (93, 94). Cells attach to the ECM 
through a special type of membrane-bound adhesion molecule 
known as integrins, which are comprised of two interacting subu-
nits. The vertebrate integrin family contains 18 α and 8 β subunits 
that can assemble into 24 different receptor complexes, each 
with unique binding properties for different ECM components 
(93). In the context of the stem cell niche of a variety of organ 
systems, the interactions between ECM proteins and integrins are 
fundamental for establishing a balance between self-renewal and 
differentiation. By forming complexes with different membrane 
receptors and ECM components, integrins facilitate a strict com-
partmentalization of cellular responses to different factors on a 
cell-by-cell basis. Such highly precise control is fundamental to 
the process of asymmetric division, a fundamental characteristic 
of self-renewing cells. The complexes that contain integrins, ECM 
components, and other receptors induce the establishment of cell 
polarity, restricting fate-determinant molecules to one pole and 
directing the plane of cell cleavage in such a way that signaling 
molecules will be asymmetrically distributed between the daugh-
ter cells (95). In fact, certain types of integrins have been recog-
nized as crucial for stem cell maintenance in different tissues (96). 
Supporting this observation, genetic ablation of β1 integrin favors 
a symmetric pattern of cell division in the mammary stem cell 
niche, leading to exhaustion of the stem cell compartment (97). 
Finally, biophysical and biochemical properties of the substrate, 
such as shape, stiffness, and protein composition, can trigger 
different transcriptional programs that support either stem cell 
maintenance or differentiation (98, 99).
Despite the emerging importance of ECM in tissue homeosta-
sis and stem cell biology, few studies have addressed its roles in the 
adrenal. Early studies in different species have shown that several 
ECM components and integrins follow a zonal distribution in the 
adrenal cortex (100, 101). Furthermore, in vitro studies on pri-
mary adrenal cultures grown on different substrates suggest that 
different ECM components affect cellular responses to ACTH. 
For instance, it has been demonstrated in primary cultures from 
human fetal adrenals that laminin exerts an inhibitory effect 
on basal and ACTH-induced steroidogenesis, and a positive 
effect on cell proliferation (102). On the other hand, collagen 
IV and fibronectin increased cortisol and DHEAS production, 
respectively (102). While collagen IV is expressed throughout 
the human fetal adrenal gland, laminin and fibronectin follow a 
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zonal distribution, being preferentially expressed in cells of the 
definitive and the fetal zones, respectively (101). Therefore, the 
differences in cellular responses in vitro induced by these different 
ECM components parallel the functional zonation observed in 
the fetal gland: laminin suppresses differentiation and promotes 
proliferation (consistent with the cellular phenotype of the 
newly forming definitive zone), collagen IV promotes HSD3B2 
expression and cortisol production (resembling the fetal adrenal 
transitional zone), and fibronectin supports CYP17A1 expression 
and DHEAS production. Indeed, primary cultures from zG and 
zF cells from the adult rat adrenal grown on laminin-coated plates 
exhibited increased proliferation and reduced basal and ACTH-
stimulated aldosterone and cortisol production, respectively 
(103). Taken together, these results support the hypothesis that the 
ECM composition modulates cellular responses to hormone and 
growth factor stimulation, providing an additional mechanism by 
which the niche itself regulates the balance between self-renewal 
and differentiation.
CONCLUDiNG ReMARKS AND  
FUTURe PeRSPeCTiveS
In the last decade, several important aspects of the physiology 
of the adrenal cortex have been characterized, including the 
developmental origins of the different progenitor populations 
and the molecular pathways that are essential for self-renewal, 
organ remodeling, and differentiation. Additionally, several par-
acrine/autocrine bioactive compounds that initiate and maintain 
these signaling pathways have been identified. However, while the 
progenitor niche populations of other tissues, such as the skin and 
the gastrointestinal tract, are clearly defined, the progenitor niche 
of the adrenal cortex is just beginning to be characterized. Many 
features of the molecular mechanisms that govern the fate of the 
adrenocortical progenitor cells are still unknown. As discussed in 
the previous sections, several studies involving transgenic animal 
models have illuminated important observations and concepts 
central to the field. However, these studies are complex and time-
consuming. Furthermore, studying such a small yet complex 
organ like the adrenal gland imposes additional challenges. In 
the near future, innovative techniques that allow investigators 
to engage in more complex in vitro studies have the potential to 
move the field forward greatly. Among these, organoid culture 
and engineered ECM are promising approaches.
Organoid culture has emerged in recent years as a valuable 
tool to study several aspects of stem cell biology, tissue mor-
phogenesis, and lineage specification (104, 105). Organoids are 
self-organizing three-dimensional structures that are derived 
from stem cells and exhibit organotypic anatomic and functional 
features, including spatially restricted lineage commitment 
(106, 107). Organoids can be grown in  vitro from pluripotent 
stem cells (embryonic stem cells and induced pluripotent stem 
cells) or organ-specific stem cells (105). Organoid cultures have 
been established for different mouse and human tissues, includ-
ing intestines, stomach, lungs, mammary gland, and prostate 
(108–114). A crucial requirement for establishing an organoid 
culture is the supplementation of organ-specific and well-defined 
stem cell niche factors in the culture medium. For example, to 
culture intestinal organoids, culture medium is supplemented 
with Wnt3a, EGF, Noggin, and R-spondin 1 (108). Organoids 
have been proven to be valuable models for studying different 
aspects developmental biology and stem cell research such as 
tissue morphogenesis, organogenesis, differentiation, heterotypic 
interactions between different cell types, and the effects of the 
ECM on cell differentiation and behavior. However, a current 
limitation of organoid cultures is the organoid dependence on a 
suitable three-dimensional matrix. Among the most commonly 
used scaffolds are collagen and Matrigel. These substrates, how-
ever, feature variable compositions and physical properties, which 
limits studies aiming to characterize the influence of the microen-
vironment on the organoid properties (105). Furthermore, these 
substrates pose risks of immunologic reactions and pathogen 
transfer and are, therefore, unsuitable for clinical applications. 
Engineered synthetic ECM has emerged as an attractive approach 
to circumvent these limitations (115).
Engineered ECM, constructed as an artificial substrate, acts 
to mimic the original three-dimensional microenvironment of a 
given organ or tissue. Increasingly, sophisticated scaffolds com-
prised of materials, such as synthetic hydrogels and nanofibers, 
are frequently employed as artificial ECM substitutes. In addition 
to biochemical interactions in cell–cell and cell–ECM signal-
ing, mechanical stimuli such as substrate stiffness, and tension 
forces can also be modeled in engineered ECM (115). In a recent 
publication Gjorevski et al. studied the effects of stiffness on the 
dynamics of single cell-derived intestinal organoid formation 
(116). While intermediate to high stiffness and the presence of 
fibronectin sustained the expansion of intestinal LGR5-positive 
stem cells, differentiation and organoid formation required softer 
matrices and the presence of laminin.
We believe that, in the near future, organoid culture and tissue 
engineering techniques will increase our power to understand the 
molecular interactions that regulate the adrenal cortex stem cell 
niche. Protocols to establish normal adrenocortical and cancer 
organoid cultures in bioengineered matrices are currently under 
development in our laboratory.
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